Literature DB >> 23169005

Association of VEGF and KDR single nucleotide polymorphisms with colorectal cancer susceptibility in Koreans.

Moon Ju Jang1, Young Joo Jeon, Jong Woo Kim, Yun Kyung Cho, Seung Ku Lee, Seong Gyu Hwang, Doyeun Oh, Nam Keun Kim.   

Abstract

Vascular endothelial growth factor (VEGF) and its receptor kinase insert domain-containing receptor (KDR) play crucial roles in angiogenesis, which contributes to the development and progression of solid tumors. The aim of this study was to investigate the associations of VEGF (-2578C > A, -1154G > A, -634G > C, and 936C > T) and KDR (-604T > C and 1192G > A) polymorphisms with the development of colorectal cancer (CRC). A total of 882 participants (390 CRC patients and 492 controls) were enrolled in the study. The genotyping of VEGF and KDR polymorphisms was performed by polymerase chain reaction-restriction fragment length polymorphism assay. We found that the CT and TT genotype of the 936C > T was associated with an increased risk of CRC compared with the CC genotype as the dominant model for the T allele. In addition, we also found a increased CRC risk with TC + CC genotype of KDR -604T > C compared with TT genotype in CRC patients and control subjects. Similarly, KDR 1192G > A also showed significant association between 1192G > A variants and risk of CRC. In the haplotype analyses, haplotype -2578A/-1154A/-634G/936T of VEGF polymorphisms and haplotype -604C/1192G and -604C/1192A of KDR polymorphisms were associated with an increased susceptibility of CRC. Our results suggest that the VEGF 936C > T, KDR -604T > C, and KDR 1192G > A polymorphisms may be contribute to CRC risk in the Korean population.
© 2012 Wiley Periodicals, Inc.

Entities:  

Keywords:  KDR; VEGF; colorectal cancer; gene-environmental effect; polymorphism

Mesh:

Substances:

Year:  2012        PMID: 23169005     DOI: 10.1002/mc.21980

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  23 in total

1.  The Importance of VEGF-KDR Signaling Pathway Genes should Not Be Ignored When the Risk of Developing Multiple Sclerosis is Taken into Consideration.

Authors:  Mehrdokht Mazdeh; Rezvan Noroozi; Jalal Gharesouran; Arezou Sayad; Alireza Komaki; Mohammad Mahdi Eftekharian; Mohsen Habibi; Mehdi Toghi; Mohammad Taheri
Journal:  J Mol Neurosci       Date:  2017-04-11       Impact factor: 3.444

2.  The relationship of kinase insert domain receptor gene polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients treated with sorafenib.

Authors:  You-Bing Zheng; Mei-Xiao Zhan; Wei Zhao; Bing Liu; Jian-Wen Huang; Xu He; Si-Rui Fu; Yan Zhao; Yong Li; Bao-Shan Hu; Li-Gong Lu
Journal:  Med Oncol       Date:  2014-09-03       Impact factor: 3.064

3.  Association of the vascular endothelial growth factor -2578C/A polymorphism with cancer risk: A meta-analysis update.

Authors:  Quanchi Chen; Zifei Zhou; Liangcheng Shan; Yingqi Hua; Hui Zeng; Pengcheng Liu; Zhengdong Cai
Journal:  Biomed Rep       Date:  2014-07-15

4.  A Candidate-Pathway Approach to Identify Gene-Environment Interactions: Analyses of Colon Cancer Risk and Survival.

Authors:  Noha Sharafeldin; Martha L Slattery; Qi Liu; Conrado Franco-Villalobos; Bette J Caan; John D Potter; Yutaka Yasui
Journal:  J Natl Cancer Inst       Date:  2015-06-13       Impact factor: 13.506

5.  Genetic Variations of Kinase Inserts Domain Receptor (KDR) Gene Are Associated with the Risk of Astrocytomas.

Authors:  Yufei Gao; Piyong Ma; Yichun He; Yan Liu; Yang Jiang
Journal:  Mol Neurobiol       Date:  2015-06-17       Impact factor: 5.590

6.  Prognostic significance of three endothelial nitric oxide synthase (eNOS) polymorphisms and metabolic syndrome (MetS) in patients with colorectal cancer.

Authors:  Eun Ju Ko; Eo Jin Kim; Hye Jung Cho; Jisu Oh; Han Sung Park; Chang Soo Ryu; Jung Oh Kim; Hak Hoon Jun; So Young Chong; Jong Woo Kim; Nam Keun Kim
Journal:  Genes Genomics       Date:  2022-04-04       Impact factor: 2.164

7.  Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy.

Authors:  T Langsenlehner; E-M Thurner; W Renner; A Gerger; K S Kapp; U Langsenlehner
Journal:  Strahlenther Onkol       Date:  2014-01-18       Impact factor: 3.621

8.  Correlational research of Golgi phosphorylation protein 3 expression in colorectal cancer.

Authors:  Yan-Ta Guo; Cheng-Zhi Qiu; Zhong-Xin Huang; Wai-Shi Yu; Xiao-Feng Yang; Ming-Zhen Wang
Journal:  World J Gastroenterol       Date:  2015-12-28       Impact factor: 5.742

9.  Investigating the association between polymorphisms in connective tissue growth factor and susceptibility to colon carcinoma.

Authors:  Abrar Ahmad; Shlear Askari; Rahel Befekadu; Victoria Hahn-Strömberg
Journal:  Mol Med Rep       Date:  2014-12-11       Impact factor: 2.952

10.  Interplay between 3'-UTR polymorphisms in the vascular endothelial growth factor (VEGF) gene and metabolic syndrome in determining the risk of colorectal cancer in Koreans.

Authors:  Young Joo Jeon; Jong Woo Kim; Hye Mi Park; Hyo Geun Jang; Jung O Kim; Jisu Oh; So Young Chong; Sung Won Kwon; Eo Jin Kim; Doyeun Oh; Nam Keun Kim
Journal:  BMC Cancer       Date:  2014-11-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.